Literature DB >> 3991834

Lateral ventricular size in schizophrenia: relationship to the disease process and its clinical manifestations.

D G Owens, E C Johnstone, T J Crow, C D Frith, J R Jagoe, L Kreel.   

Abstract

Using computed tomography, lateral ventricular size was studied in a sample of 112 institutionalized chronic schizophrenic patients (selected from 510 cases to investigate the correlates of the defect state and intellectual decline and the effects of insulin, electroconvulsive and neuroleptic treatment), and compared with matched groups of non-institutionalized schizophrenics, patients with first schizophrenic episodes, institutionalized and non-institutionalized patients with primary affective disorder, and neurotic out-patients. Age was significantly correlated (P less than 0.0002) with lateral ventricular size, but the institutionalized schizophrenic patients had significantly larger (P less than 0.025) lateral ventricles than the neurotics when age was taken into account. Ventricular enlargement was unrelated to past physical treatment (neuroleptics, insulin coma and electroconvulsive therapy). Within the group of institutionalized schizophrenic patients few correlates of ventricular enlargement were identified; thus in this population increased ventricular size was not clearly associated with the features of the defect state (negative symptoms and intellectual impairment). However, there was a curvilinear (inverted-U) relationship between intellectual function and ventricular size. Increased ventricular size was significantly related to absence of hallucinations, impairment of social behaviour, inactivity and the presence of abnormal involuntary movements. The findings confirm that structural brain changes do occur in chronic schizophrenia, but illustrate some of the difficulties in elucidating the clinical significance of ventricular enlargement. Lateral ventricular size is strongly age-related and the distribution in chronic schizophrenia is skewed and not bimodal; the relationship to particular features of the disease is complex and likely to emerge only in studies with a large sample size.

Entities:  

Mesh:

Year:  1985        PMID: 3991834     DOI: 10.1017/s0033291700020900

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  12 in total

Review 1.  Very poor outcome schizophrenia: clinical and neuroimaging aspects.

Authors:  Serge A Mitelman; Monte S Buchsbaum
Journal:  Int Rev Psychiatry       Date:  2007-08

2.  Topographic subtypes of tardive dyskinesia in schizophrenic patients aged less than 60 years: relationship to demographic, clinical, treatment, and neuropsychological variables.

Authors:  O Gureje
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-12       Impact factor: 10.154

3.  Dementia as a complication of schizophrenia.

Authors:  P J de Vries; W G Honer; P M Kemp; P J McKenna
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-05       Impact factor: 10.154

Review 4.  The ageing brain, neuroleptic drugs and the enigma of schizophrenia.

Authors:  J L Waddington
Journal:  Ir J Med Sci       Date:  1988-05       Impact factor: 1.568

5.  Computed tomographic findings in schizophrenia: relation with symptom dimensions and sex differences.

Authors:  A K Malla; J Takhar; R M Norman; L Assis
Journal:  J Psychiatry Neurosci       Date:  1999-03       Impact factor: 6.186

6.  A computed tomographic study of schizophrenia.

Authors:  N Lal; S C Tewari; P K Dalal; N Kohli; S Srivastava
Journal:  Indian J Psychiatry       Date:  1997-04       Impact factor: 1.759

7.  Clinical correlates of postmortem brain changes in schizophrenia: decreased brain weight and length correlate with indices of early impairment.

Authors:  E C Johnstone; C J Bruton; T J Crow; C D Frith; D G Owens
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-04       Impact factor: 10.154

8.  The impact of neuroleptic medication on tardive dyskinesia: a meta-analysis of published studies.

Authors:  H Morgenstern; W M Glazer; D Niedzwiecki; P Nourjah
Journal:  Am J Public Health       Date:  1987-06       Impact factor: 9.308

9.  Plasma nitrate levels in deficit versus non-deficit forms of schizophrenia.

Authors:  Eiji Suzuki; Toshio Nakaki; Makoto Nakamura; Hitoshi Miyaoka
Journal:  J Psychiatry Neurosci       Date:  2003-07       Impact factor: 6.186

10.  Temporal lobe structure as determined by nuclear magnetic resonance in schizophrenia and bipolar affective disorder.

Authors:  E C Johnstone; D G Owens; T J Crow; C D Frith; K Alexandropolis; G Bydder; N Colter
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-06       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.